Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Signature(s)

Amount
€ 250,000,000
Countries
Sector(s)
Spain : € 250,000,000
Health : € 250,000,000
Signature date(s)
16/02/2023 : € 250,000,000
Link to source

Summary sheet

Release date
19 December 2022
Status
Reference
Signed | 16/02/2023
20190114
Project name
Promoter - financial intermediary
MADRID HEALTHCARE INVESTMENTS
COMUNIDAD AUTONOMA DE MADRID
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 250 million
EUR 518 million
Location
Sector(s)
  • Health - Human health and social work activities
Description
Objectives

This project concerns investments in hospitals and primary care centres in the region of Madrid

The project supports selected healthcare investments conducted by the Comunidad Autónoma de Madrid (CAM) including the new construction, rehabilitation and equipment of 6 medium and longterm care hospitals and 11 primary care centres in the Madrid region, extension and modernisation of clinical departments within 5 hospitals and the renovation of high complexity medical equipment in hospitals and clinics. The project will address the issues of aging population and access to healthcare services in the Madrid region. It will also improve the quality of healthcare services by supporting the purchase of high-end, up to date medical equipment. The project will be located in the Autonomous Community of Madrid.

Additionality and Impact

The project supports EIB's Health policy objective, is in line with the Urban Agenda for the EU, and aims to contribute to the priority objective of the European Commission to "make public health systems more cost-effective, equitable and sustainable". The project generates positive externalities and economic benefits through the provision of improved healthcare services including enhanced preparedness to respond to increasing demand for care by an ageing population, potential future health emergencies, and the reduction of energy consumption that benefits society and the broader economy. The project finances investment in innovative medical equipment, thus contributes to the Horizon 2020 objective.


EIB's participation will provide a financial benefit to CAM as it allows to distribute the cost of financing in the long term, resulting in a manageable annual debt service amount. The EIB will include flexible drawdown terms and conditions adjusted to the investment horizon of the Project., which are highly valued by public promoters and a key differentiating feature of EIB's financing. The EIB loan could have a signalling effect, facilitating additional financing for Healthcare programmes from complementary sources which will reduce the funding uncertainly for these type of programmes in CAM.

Environmental aspects
Procurement

The project comprises of the construction and equipping of medical facilities. Hospitals, primary care centres, etc. are not specifically mentioned in the environmental impact assessment directive 2011/92/EU amended by Directive 2014/52/EU, though the project is covered by Annex II of the Directive in relation to urban development. The Bank's services will verify during appraisal the screening decision of the competent authority. In line with Directive 2010/31/EU, the new and rehabilitated buildings will have to meet at least the relevant national targets on energy efficiency. The energy performance of the hospital and any specific related targets to be met, will be verified during appraisal. It is expected that the project will bring wider benefits to the community as healthcare is an element of social cohesion and economic development. The Bank will encourage the Promoter to take into account the circular economy principles during the development and future operation of the project.

The Bank will require the Promoter to ensure that contracts for the implementation of the project have been and will be tendered in accordance with the relevant applicable EU procurement legislation: Directive 2014/24/EU, as well as Directive 89/665/EEC as interpreted by the Court of Justice of the EU, with publication of tender notices in the EU Official Journal, as and where required.

Milestone
Under appraisal
Approved
Signed
8 December 2022
16 February 2023
Link to source
Other links

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - MADRID HEALTHCARE INVESTMENTS
Publication Date
11 Jan 2023
Document language
Main Topic
Lending
Document Number
158973330
Document Focus
Environmental Information
Project Number
20190114
Sector(s)
Regions
Countries
Publicly available
Download now

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications